Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof

Details for Australian Patent Application No. 2008309003 (hide)

Owner GlaxoSmithKline LLC

Inventors Thomson, Stephen Andrew; Dickerson, Scott Howard; Banker, Pierette; Boros, Eric Eugene; Koble, Cecilia S.; Martin, Michael Tolar; Kaldor, Istvan; Sparks, Steven Meagher

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008309003

PCT Pub. Number WO2009/045830

Priority 60/975,862 28.09.07 US

Filing date 25 September 2008

Wipo publication date 9 April 2009

International Classifications

C07C 275/34 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/045830 Priority application(s): WO2009/045830

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309004-Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof

2008309000-Method and apparatus for generating radio link control protocol data units